BiotechTube
Home/Apogee Biotechnology/Charles D. Smith, Ph.D.
CD

Charles D. Smith, Ph.D.

Founder

Apogee Biotechnology

Therapeutic Areas

OncologyInflammatory DiseasesAutoimmune DiseasesInfectious Disease

Apogee Biotechnology Pipeline

DrugIndicationPhase
ABC294640 (Opaganib)Cholangiocarcinoma (Bile Duct Cancer)Phase 2